MS Speaks

HERE FOR 19 YEARS--for people with an interest in multiple sclerosis

Pages: [1]

		Subject / Started by	Replies / Views	Last post
		(Abst.) Projected study investigating relationship between fingolimod and skin cancer risk (Abst.) Projected study investigating relationship between fingolimod and skin cancer risk agate · January 26, 2025, 04:02:29 pm From PubMed (January 26, 2025)--"Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-bas... 0 Replies · 163 Views Started by agate	0 Replies 163 Views	January 26, 2025, 04:02:29 pm by agate
		Rebound syndrome in MS patients after stopping Gilenya Rebound syndrome in MS patients after stopping Gilenya agate · February 17, 2016, 10:44:11 am Being presented at the annual ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis) conference in New Or... 4 Replies · 10702 Views Started by agate	4 Replies 10702 Views	April 25, 2022, 07:00:56 am by agate
		Randomized clinical trial: 2 fingolimod doses vs. Copaxone for patients with RRMS Randomized clinical trial: 2 fingolimod doses vs. Copaxone for patients with RRMS agate · August 25, 2020, 09:15:13 pm From JAMA (August 24, 2020)--"Efficacy and safety of 2 fingolimod doses vs. glatiramer acetate for the treatment of patients wi... 0 Replies · 358 Views Started by agate	0 Replies 358 Views	August 25, 2020, 09:15:13 pm by agate
		FDA approves first generics of Gilenya FDA approves first generics of Gilenya agate · December 25, 2019, 04:16:44 pm From MS Focus.org (the MS Foundation), December 11, 2019--"FDA Approves First Generics of Gilenya":https://msfocus.org/About-Us... 0 Replies · 231 Views Started by agate	0 Replies 231 Views	December 25, 2019, 04:16:44 pm by agate
		Fingolimod and liver injury research information (PubMed) Fingolimod and liver injury research information (PubMed) agate · November 01, 2019, 06:08:19 pm From PubMed, the Overview section on fingolimod in the report entitled LiverTox: Clinical and Research Information on Drug-Induc... 0 Replies · 271 Views Started by agate	0 Replies 271 Views	November 01, 2019, 06:08:19 pm by agate
		(Abst.) Gilenya vs. Tecfidera in MS... (Abst.) Gilenya vs. Tecfidera in MS... agate · June 08, 2018, 09:02:03 pm From PubMed, June 8, 2018--"Fingolimod vs. dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study... 0 Replies · 408 Views Started by agate	0 Replies 408 Views	June 08, 2018, 09:02:03 pm by agate
		(Abst.) PML after fingolimod treatment (Abst.) PML after fingolimod treatment agate · April 21, 2018, 02:57:03 pm "Progressive multifocal leucoencephalopathy after fingolimod treatment"--from PubMed, April 21, 2018:https://www.ncbi.nlm.nih.go... 1 Replies · 545 Views Started by agate	1 Replies 545 Views	May 19, 2018, 04:21:31 pm by agate
		Gilenya shows promise in pediatric MS Gilenya shows promise in pediatric MS agate · September 06, 2017, 08:19:57 pm From MedPage Today, September 5, 2017: "MS Drug Works in Kids" 1 Replies · 612 Views Started by agate	1 Replies 612 Views	May 14, 2018, 08:47:09 pm by agate
		(Abst.) Switching from Tysabri to Gilenya within 6 weeks cuts recurrence of MS disease activity (Abst.) Switching from Tysabri to Gilenya within 6 weeks cuts recurrence of MS disease activity agate · August 22, 2017, 05:52:26 am From PubMed, August 22, 2017:QuoteMult Scler. 2017 Aug 1:1352458517726381. Switching natalizumab to fingolimod within 6 weeks re... 0 Replies · 482 Views Started by agate	0 Replies 482 Views	August 22, 2017, 05:52:26 am by agate
		(AAN abst.) Alternate dosing of fingolimod for MS (AAN abst.) Alternate dosing of fingolimod for MS agate · May 16, 2017, 11:53:39 am Presented as a platform session at the AAN annual meeting in Boston in April 2017:QuoteAlternate dosing of fingolimod for multip... 0 Replies · 649 Views Started by agate	0 Replies 649 Views	May 16, 2017, 11:53:39 am by agate
		(Abst.) Extensive white matter lesions after 2 yrs. of fingolimod: PML or MS relapse? (Abst.) Extensive white matter lesions after 2 yrs. of fingolimod: PML or MS relapse? agate · December 26, 2016, 02:19:11 pm From Multiple Sclerosis Journal, December 23, 2016:QuoteExtensive white matter lesions after 2 years of fingolimod: Progressive ... 0 Replies · 403 Views Started by agate	0 Replies 403 Views	December 26, 2016, 02:19:11 pm by agate
		New EMA advice for PML prevention with fingolimod in MS New EMA advice for PML prevention with fingolimod in MS agate · December 19, 2015, 05:44:35 pm EMA = European Medicines Agency. It has been in existence for 20 years and monitors medicines used throughout the European Union... 0 Replies · 334 Views Started by agate	0 Replies 334 Views	December 19, 2015, 05:44:35 pm by agate
		3rd PML case with Gilenya in MS 3rd PML case with Gilenya in MS agate · August 18, 2015, 02:52:04 pm From Medscape, August 18, 2015:QuoteThird Case of PML With Fingolimod (Gilenya) in MSMegan BrooksFreelance writer, MedscapeDiscl... 0 Replies · 361 Views Started by agate	0 Replies 361 Views	August 18, 2015, 02:52:04 pm by agate
		Gilenya label to include PML warning according to FDA Gilenya label to include PML warning according to FDA agate · August 04, 2015, 02:29:30 pm From MedPage Today, August 4, 2015:QuoteFDA Warns of Fingolimod PML CasesNeither patient had been on a previous immunosuppressiv... 1 Replies · 390 Views Started by agate	1 Replies 390 Views	August 06, 2015, 05:22:34 am by agate
		(Abst.) Lymphomatoid papulosis in patient on Gilenya for MS (Abst.) Lymphomatoid papulosis in patient on Gilenya for MS agate · July 31, 2015, 09:17:45 am From Multiple Sclerosis Journal, July 30, 2015:QuoteLymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patien... 0 Replies · 369 Views Started by agate	0 Replies 369 Views	July 31, 2015, 09:17:45 am by agate
		Fingolimod in MS: Indication of added benefit in certain patients Fingolimod in MS: Indication of added benefit in certain patients agate · July 08, 2015, 02:01:35 pm From Medical News Today, July 7, 2015:QuoteFingolimod in RRMS: Indication of added benefit in certain patientsReassessment based... 0 Replies · 323 Views Started by agate	0 Replies 323 Views	July 08, 2015, 02:01:35 pm by agate
		PML case in MS patient taking Gilenya PML case in MS patient taking Gilenya agate · March 10, 2015, 02:34:07 pm From the Novartis Website:QuoteGilenya Safety UpdateFebruary 16, 2015 17:00 CETNovartis confirms that it has received a report o... 0 Replies · 360 Views Started by agate	0 Replies 360 Views	March 10, 2015, 02:34:07 pm by agate
		Increased risk of zoster infections with Gilenya Increased risk of zoster infections with Gilenya agate · December 22, 2014, 07:15:53 pm From MedPage Today, November 24, 2014:QuoteMS Focus: Gilenya Ups Zoster RiskRisk with fingolimod doubled compared with placebo b... 1 Replies · 474 Views Started by agate	1 Replies 474 Views	January 14, 2015, 04:30:34 pm by agate

Pages: [1]

Normal Topic
Hot Topic (More than 15 replies)
Very Hot Topic (More than 1 replies)

Locked Topic
Sticky Topic
Poll

Create your own free forum at CreateAForum.com | Report Abuse